<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Arq Bras Cardiol</journal-id><journal-id journal-id-type="iso-abbrev">Arq. Bras. Cardiol</journal-id><journal-title-group><journal-title>Arquivos Brasileiros de Cardiologia</journal-title></journal-title-group><issn pub-type="ppub">0066-782X</issn><issn pub-type="epub">1678-4170</issn><publisher><publisher-name>Sociedade Brasileira de Cardiologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25098373</article-id><article-id pub-id-type="pmc">4193067</article-id><article-id pub-id-type="doi">10.5935/abc.20140108</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Effects of Exercise Training on Heart Rate Variability in Chagas Heart
Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nascimento</surname><given-names>Bruno Ramos</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="aff" rid="aff02">2</xref><xref ref-type="aff" rid="aff03">3</xref><xref ref-type="corresp" rid="c01"/></contrib><contrib contrib-type="author"><name><surname>Lima</surname><given-names>M&#x000e1;rcia Maria Oliveira</given-names></name><xref ref-type="aff" rid="aff03">3</xref><xref ref-type="aff" rid="aff04">4</xref></contrib><contrib contrib-type="author"><name><surname>Nunes</surname><given-names>Maria do Carmo Pereira</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="aff" rid="aff02">2</xref><xref ref-type="aff" rid="aff03">3</xref></contrib><contrib contrib-type="author"><name><surname>de Alencar</surname><given-names>Maria Clara Noman</given-names></name><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Costa</surname><given-names>Henrique Silveira</given-names></name><xref ref-type="aff" rid="aff03">3</xref></contrib><contrib contrib-type="author"><name><surname>Pinto Filho</surname><given-names>Marcelo Martins</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="aff" rid="aff02">2</xref></contrib><contrib contrib-type="author"><name><surname>Cota</surname><given-names>Vitor Emanuel Serafim</given-names></name><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Rocha</surname><given-names>Manoel Ot&#x000e1;vio da Costa</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="aff" rid="aff03">3</xref></contrib><contrib contrib-type="author"><name><surname>Ribeiro</surname><given-names>Antonio Luiz Pinho</given-names></name><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="aff" rid="aff02">2</xref><xref ref-type="aff" rid="aff03">3</xref></contrib></contrib-group><aff id="aff01"><label>1</label> Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo
Horizonte, MG - Brazil</aff><aff id="aff02"><label>2</label> Servi&#x000e7;o de Cardiologia e Cirurgia Cardiovascular do Hospital das
Cl&#x000ed;nicas da UFMG, Belo Horizonte, MG - Brazil</aff><aff id="aff03"><label>3</label> P&#x000f3;s-gradua&#x000e7;&#x000e3;o em Infectologia e Medicina Tropical -
Faculdade de Medicina da UFMG, Belo Horizonte, MG - Brazil</aff><aff id="aff04"><label>4</label> Escola de Fisioterapia da Universidade Federal dos Vales do Jequitinhonha e
Mucuri, Diamantina, MG - Brazil</aff><author-notes><corresp id="c01"><bold>Mailing Address: Bruno Ramos Nascimento,</bold> Rua Tenente Garro, 137, apt. 1202,
Santa Efig&#x000ea;nia. Postal Code 30240-360, Belo Horizonte, MG - Brazil. E-mail:
<email>ramosnas@cardiol.br</email>; <email>ramosnas@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>9</month><year>2014</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>9</month><year>2014</year></pub-date><volume>103</volume><issue>3</issue><fpage>201</fpage><lpage>208</lpage><history><date date-type="received"><day>27</day><month>12</month><year>2013</year></date><date date-type="rev-recd"><day>12</day><month>5</month><year>2014</year></date><date date-type="accepted"><day>13</day><month>5</month><year>2014</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted non-commercial
use, distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Background:</title><p>Heart rate variability (HRV) is a marker of autonomic dysfunction severity. The effects
of physical training on HRV indexes in Chagas heart disease (CHD) are not well
established.</p></sec><sec><title>Objective:</title><p>To evaluate the changes in HRV indexes in response to physical training in CHD.</p></sec><sec><title>Methods:</title><p>Patients with CHD and left ventricular (LV) dysfunction, physically inactive, were
randomized either to the intervention (IG, N = 18) or control group (CG, N = 19). The IG
participated in a 12-week exercise program consisting of 3 sessions/week.</p></sec><sec><title>Results:</title><p>Mean age was 49.5 &#x000b1; 8 years, 59% males, mean LVEF was 36.3 &#x000b1; 7.8%.
Baseline HRV indexes were similar between groups. From baseline to follow-up, total
power (TP): 1653 (IQ 625 - 3418) to 2794 (1617 - 4452) ms, p = 0.02) and very low
frequency power: 586 (290 - 1565) to 815 (610 - 1425) ms, p = 0.047) increased in the
IG, but not in the CG. The delta (post - pre) HRV indexes were similar: SDNN 11.5
&#x000b1; 30.0 vs. 3.7 &#x000b1; 25.1 ms. p = 0.10; rMSSD 2 (6 - 17) vs. 1 (21 - 9) ms. p
= 0.43; TP 943 (731 - 3130) vs. 1780 (921 - 2743) Hz. p = 0.46; low frequency power
(LFP) 1.0 (150 - 197) vs. 60 (111 - 146) Hz. p = 0.85; except for high frequency power,
which tended to increase in the IG: 42 (133 - 92) vs. 79 (61 - 328) Hz. p = 0.08).</p></sec><sec><title>Conclusion:</title><p>In the studied population, the variation of HRV indexes was similar between the active
and inactive groups. Clinical improvement with physical activity seems to be independent
from autonomic dysfunction markers in CHD.</p></sec></abstract><kwd-group><kwd>Chagas Cardiomyopathy</kwd><kwd>Exercise</kwd><kwd>Heart Rate</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Chagas disease is an infection caused by the <italic>Trypanosoma cruzi</italic> ,
transmitted primarily by insects of the Triatominae family. It is estimated than 8-10
million people are infected worldwide, especially in Latin America, where the disease is
still endemic<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref></sup>. Chagas cardiomyopathy (CHD) affects 20-40% of patients with the chronic
form, and its pathogenesis is closely linked to neurogenic mechanisms, microvascular
dysfunction, autoimmune processes and direct injury by the parasite<sup><xref rid="r02" ref-type="bibr">2</xref>-<xref rid="r04" ref-type="bibr">4</xref></sup>.</p><p>Cardiac autonomic dysfunction is known to be a characteristic and early finding of Chagas
disease<sup><xref rid="r05" ref-type="bibr">5</xref>-<xref rid="r09" ref-type="bibr">9</xref></sup>, possibly related to deposits of autoantibodies<sup><xref rid="r10" ref-type="bibr">10</xref></sup>, causing desensitization of cardiac
neurotransmitter receptors, early affecting cardiac vagal control<sup><xref rid="r11" ref-type="bibr">11</xref></sup>. The heart rate variability (HRV) is an indirect measure of
the interactions between the sympathetic and parasympathetic systems, mediated by several
physiological mechanisms such as reflex arcs, release of cytokine and vasoactive substances,
among others. The values of HRV measurements in the time and frequency domains are known
diagnostic, prognostic markers and predictors of complications, including mortality, in
several systemic diseases, such as heart failure and sepsis<sup><xref rid="r12" ref-type="bibr">12</xref>-<xref rid="r14" ref-type="bibr">14</xref></sup>.</p><p>Among the non-pharmacological measures in the treatment of cardiovascular diseases, regular
physical activity as a factor of vagal tone increase has shown a major impact on HRV indices
and association with training intensity<sup><xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref></sup>. Significant HRV impairment has been
demonstrated in CHD<sup><xref rid="r17" ref-type="bibr">17</xref></sup>, but studies suggest
that, unlike other forms of heart failure, there seems to be a change in the association
between physical exercise and HRV<sup><xref rid="r18" ref-type="bibr">18</xref></sup>, with
no significant improvement of their indices being observed after supervised training
programs<sup><xref rid="r05" ref-type="bibr">5</xref></sup>.</p><p>The objective of this study is to evaluate the changes of HRV indexes in the time and
frequency domains in patients with Chagas heart disease and left ventricular dysfunction
undergoing supervised exercise training for 12 weeks, compared with the inactive group of
patients with the same clinical characteristics.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Study population and inclusion criteria</title><p>A complete description of the study design has been published previously<sup><xref rid="r19" ref-type="bibr">19</xref></sup>. Briefly, 145 subjects were recruited from
the Cardiology and Chagas Disease Outpatient Clinics of Hospital das Clinicas,
Universidade Federal de Minas Gerais. The volunteers were interviewed to obtain clinical
history and current life habits. To be eligible for the study, patients had to have a
previous diagnosis of CHD, based on at least two positive serologic tests for Trypanosoma
cruzi antibodies, along with the presence of left ventricular dysfunction and capacity to
attend the training program fully<sup><xref rid="r04" ref-type="bibr">4</xref></sup>.
Patients with comorbidities, patients with pacemaker or resynchronization device and those
that self-reported to be physically active were excluded. Forty patients met the inclusion
criteria.</p><p>All patients had been clinically stable for at least three months, had sinus rhythm and
were receiving standard medical therapy<sup><xref rid="r20" ref-type="bibr">20</xref></sup>. After randomization, carried out through an electronic system,
patients were allocated to the intervention group (IG) or control group (CG). Informed
consent was obtained from all patients, and the study was approved by the Research Ethics
Committee of Universidade Federal de Minas Gerais, in accordance with the Declaration of
Helsinki.</p></sec><sec><title>Study design and procedures</title><p>At the moment of inclusion, all patients underwent clinical examination, laboratory
tests, 12-lead ECG, symptom-limited exercise stress test to establish training heart rate
(HR) intensity, 6-minute walk test (6MWT), echocardiography and 24-h Holter monitoring to
assess HRV indices. Functional capacity was assessed by Goldman and New York Heart
Association (NYHA) criteria. Severity of cardiac impairment was determined by
echocardiographic indices (ejection fraction, EF, and left ventricular end diastolic
volume, LVEDV). All tests were performed in a two-week period before and after aerobic
training. Examiners were blinded to the results of the other tests.</p><p>A symptom-limited exercise stress was performed on a treadmill (Digistress Pulsar
Micromed, Brasilia, Brazil) using the Bruce protocol. Continuous monitoring was performed
with 12-lead ECG, recorded every minute. Blood pressure was measured manually with a cuff
in the standing position in the last 30 seconds of each stage and for four minutes in the
recovery period. Heart rate was determined by ECG and the chronotropic response was
calculated as the achieved percentage of heart rate predicted for age, according to the
Astrand formula (220 - age) at peak exercise. The 6-minute walk test (6MWT) was performed
according to standard protocol<sup><xref rid="r21" ref-type="bibr">21</xref></sup> with
two walks at maximum walking speed in a 30-meter corridor, separated by a 15-minute
interval. A HR monitor (Polar FS2, Electro, Kempele, Finland) and a pulse oximeter
(NoninOnyx 9500, Plymouth, Minnesota, USA) were used in the assessment.</p><p>24 h-Holter monitoring was performed using a portable three-channel tape recorder
(Dynamics, Cardios, S&#x000e3;o Paulo, Brazil), at the beginning and end of the study.
Subjects were instructed to maintain their normal daily activities during the recording.
HRV analysis was performed when a good quality tracing of at least 18 h was available on a
Burdick/DMI/Cardios Hospital Holter System (Spacelabs Burdick, Deerfield, Wisconsin, Sao
Paulo, Brazil). Tracings were analyzed for five minutes every hour, and the sleep period
with the loweat HR was used as reference.</p><p>The HRV indices were calculated in the time domain (SDNN: standard deviation of normal RR
intervals; rMSSD: Root Mean Square of Successive Differences) and frequency domain (TP,
total power; VLFP: very low frequency power; LFP: low frequency power; HFP, high frequency
power).</p></sec><sec><title>Physical training protocol</title><p>The IG patients participated in a supervised program consisting of three sessions per
week, on alternate days, totaling 36 sessions in 12 weeks, as detailed in a previous
publication<sup><xref rid="r19" ref-type="bibr">19</xref></sup>. Briefly, the protocol
consisted of warm-up exercises for 15 minutes, followed by a 30 minute-walk and 15 minutes
of cooling down. Exercise intensity was based on peak HR achieved on a treadmill test
limited by symptoms and calculated by the Karvonen formula (maximal HR - HR at rest)
50-70% + resting HR<sup><xref rid="r22" ref-type="bibr">22</xref></sup> and was adjusted
throughout the program. The CG patients were instructed to maintain their daily routines
and were asked about physical activities during consultations.</p></sec><sec><title>Statistical Analysis</title><p>Statistical analysis was performed using SPSS software version 20.0 for Mac OSX (SPSS
Inc., Chicago, Illinois, United States of America). For this analysis, a sample of 36
patients was calculated to detect a 15% difference in SDNN variation between groups, with
&#x003b1; error = 5% and &#x003b2; error = 20%. Descriptive analysis of continuous and
categorical variables was performed. The presence or absence of normal distribution of
variables was performed with the Shapiro-Wilk's test. Continuous data were expressed as
mean &#x000b1; standard deviation or as median and interquartile (IQ) range Q1 - Q3
(25-75%) when presenting with non-normal distribution. Categorical variables were
expressed as absolute values and percentages. Variations in measurements at the beginning
and end of the study were expressed as delta values (&#x02206;).</p><p>To evaluate the changes in continuous variables in relation to baseline, the paired
Student's <italic>t</italic> test was used for normally distributed variables or paired
Wilcoxon test if the distribution was not normal. The comparison of means between groups
was performed using Student's <italic>t</italic> test for continuous variables with normal
distribution and the Mann-Whitney test for those with non-normal distribution. The
comparison of categorical variables between groups was performed by Chi-square test. When
necessary, analysis of variance transformations were performed. A two-tailed significance
level of 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results"><title>Results</title><p>Of the 145 patients evaluated, 40 met the inclusion criteria. Throughout the study, two
patients died (one patient in each group) and one patient did not complete the proposed
procedures. The final sample consisted of 37 subjects: 18 in the IG and 19 in the CG.
Demographic, clinical and echocardiographic characteristics of the groups are shown in <xref ref-type="table" rid="t01">Table 1</xref>. The male gender predominated and most patients
had NYHA functional class I, with mean left ventricular ejection fraction (LVEF) &#x0003c; 40%.
The only characteristic that differed between IG and CG was body mass index (BMI). Regarding
medication, all patients received angiotensin-converting enzyme inhibitors (ACEI); 22.2% and
21.1% (p = 1.00), respectively, were taking beta-blockers; 22.2% and 15.8% (p = 0.693) were
taking digitalis; 77.8% and 84.2% (p = 0.62) used amiodarone. The IG patients had complete
adherence to the training program and, in the event of non-attendance, a new session was
scheduled.</p><table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><p>Comparison of clinical, demographic and echocardiographic characteristics between the
control and intervention groups</p></caption><table frame="hsides" rules="rows"><thead><tr><th align="left" rowspan="1" colspan="1">
<bold>Characteristic</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Control Group (n = 19)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Intervention Group (n = 18)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>p</bold>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Male gender (n, %)</td><td align="center" rowspan="1" colspan="1">12 (63.2%)</td><td align="center" rowspan="1" colspan="1">10 (55.6%)</td><td align="center" rowspan="1" colspan="1">0.74</td></tr><tr><td rowspan="1" colspan="1">Age, years (mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">50.1 &#x000b1; 6.6</td><td align="center" rowspan="1" colspan="1">48.6 &#x000b1; 9.0</td><td align="center" rowspan="1" colspan="1">0.55</td></tr><tr><td rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>, median IQ)</td><td align="center" rowspan="1" colspan="1">22.5 (21.5-24.8)</td><td align="center" rowspan="1" colspan="1">24.6 (23.7-27.9)</td><td align="center" rowspan="1" colspan="1">0.042*</td></tr><tr><td rowspan="1" colspan="1">SBP at rest (mmHg, median IQ)</td><td align="center" rowspan="1" colspan="1">120 (110-130)</td><td align="center" rowspan="1" colspan="1">115 (110-120)</td><td align="center" rowspan="1" colspan="1">0.13</td></tr><tr><td rowspan="1" colspan="1">DBP at rest (mmHg, median IQ)</td><td align="center" rowspan="1" colspan="1">80 (70-80)</td><td align="center" rowspan="1" colspan="1">80 (70-80)</td><td align="center" rowspan="1" colspan="1">0.987</td></tr><tr><td rowspan="1" colspan="1">Functional class NYHA I/II (n, %)</td><td align="center" rowspan="1" colspan="1">14 (73.7%)/5 (26.3%)</td><td align="center" rowspan="1" colspan="1">10 (55.6%)/8 (44.4%)</td><td align="center" rowspan="1" colspan="1">0.31</td></tr><tr><td rowspan="1" colspan="1">Functional class Goldman I/II/III (n, %)</td><td align="center" rowspan="1" colspan="1">12 (63.2%)/5 (26.3%)/2 (10.5%)</td><td align="center" rowspan="1" colspan="1">10 (55.6%)/7 (38.9%)/3 (8.1%)</td><td align="center" rowspan="1" colspan="1">0.66</td></tr><tr><td rowspan="1" colspan="1">LVEF (%, mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">37.1 &#x000b1; 7.6</td><td align="center" rowspan="1" colspan="1">36.6 &#x000b1; 7.4</td><td align="center" rowspan="1" colspan="1">0.84</td></tr><tr><td rowspan="1" colspan="1">LVDD (mm, mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">50.3 &#x000b1; 5.4</td><td align="center" rowspan="1" colspan="1">50.9 &#x000b1; 7.3</td><td align="center" rowspan="1" colspan="1">0.77</td></tr><tr><td rowspan="1" colspan="1">LVDS (mm, mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">64.0 &#x000b1; 4.9</td><td align="center" rowspan="1" colspan="1">64.2 &#x000b1; 5.6</td><td align="center" rowspan="1" colspan="1">0.90</td></tr></tbody></table><table-wrap-foot><fn><p>SD: standard deviation; LVEF: left ventricular ejection fraction; BMI: body mass
index; IQ: interquartile range (25-75); NYHA functional class - New York Heart
Association; DBP: diastolic blood pressure; SBP: systolic blood pressure; LVDD: left
ventricular diameter during diastole; LVDS: left ventricular diameter during
systole.</p></fn></table-wrap-foot></table-wrap><p>In relation to the baseline 12-lead ECG, the characteristics were similar between the IG
and CG groups (<xref ref-type="table" rid="t02">Table 2</xref>), except for lower HR in IG
and greater PR interval in this group. Regarding the 24-h Holter variables, the groups were
also similar (<xref ref-type="table" rid="t02">Table 2</xref>), except for mean and minimum
HR, which were lower in the IG (<xref ref-type="table" rid="t02">Table 2</xref>).</p><table-wrap id="t02" orientation="portrait" position="float"><label>Table 2</label><caption><p>Comparison of electrocardiographic baseline and 24-h Holter variables between the
control group and the intervention group</p></caption><table frame="hsides" rules="rows"><thead><tr><th align="left" rowspan="1" colspan="1">
<bold>Variable</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Control group (n = 19)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Intervention group (n = 18)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>p</bold>
</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">
<bold/>
</td><td colspan="2" align="center" rowspan="1">Baseline ECG</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">HR (bpm, median IQ))</td><td align="center" rowspan="1" colspan="1">64(55-73)</td><td align="center" rowspan="1" colspan="1">56 (52-60)</td><td align="center" rowspan="1" colspan="1">0.036<xref ref-type="table-fn" rid="tfn01t02">*</xref></td></tr><tr><td rowspan="1" colspan="1">PRi Interval (ms, median IQ)</td><td align="center" rowspan="1" colspan="1">160 (151-194)</td><td align="center" rowspan="1" colspan="1">192 (175-230)</td><td align="center" rowspan="1" colspan="1">0.029<xref ref-type="table-fn" rid="tfn01t02">*</xref></td></tr><tr><td rowspan="1" colspan="1">QRS duration (ms, median IQ)</td><td align="center" rowspan="1" colspan="1">135 (96-150)</td><td align="center" rowspan="1" colspan="1">147 (118-154)</td><td align="center" rowspan="1" colspan="1">0.343</td></tr><tr><td rowspan="1" colspan="1">QTc Interval (ms. mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">437 &#x000b1; 31</td><td align="center" rowspan="1" colspan="1">448 &#x000b1; 33</td><td align="center" rowspan="1" colspan="1">0.300</td></tr><tr><td rowspan="1" colspan="1">LBBB (n, %)</td><td align="center" rowspan="1" colspan="1">1 (5.3%)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td rowspan="1" colspan="1">RBBB (n, %)</td><td align="center" rowspan="1" colspan="1">10 (52.6%)</td><td align="center" rowspan="1" colspan="1">14 (77.8%)</td><td align="center" rowspan="1" colspan="1">0.170</td></tr><tr><td rowspan="1" colspan="1">LAHB (n, %)</td><td align="center" rowspan="1" colspan="1">5 (26.3%)</td><td align="center" rowspan="1" colspan="1">10 (55.5%)</td><td align="center" rowspan="1" colspan="1">0.099</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td colspan="2" align="center" rowspan="1">
<bold>Baseline 24-h Holter</bold>
</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td rowspan="1" colspan="1">Mean HR (mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">67.7 &#x000b1; 7.7</td><td align="center" rowspan="1" colspan="1">61.7 &#x000b1; 7.5</td><td align="center" rowspan="1" colspan="1">0.023<xref ref-type="table-fn" rid="tfn01t02">*</xref></td></tr><tr><td rowspan="1" colspan="1">Minimum HR (mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">47.2 &#x000b1; 5.7</td><td align="center" rowspan="1" colspan="1">42.8 &#x000b1; 7.2</td><td align="center" rowspan="1" colspan="1">0.044<xref ref-type="table-fn" rid="tfn01t02">*</xref></td></tr><tr><td rowspan="1" colspan="1">AVB (1<sup>st</sup> and 2<sup>nd</sup> degree)</td><td align="center" rowspan="1" colspan="1">3 (15.8%)</td><td align="center" rowspan="1" colspan="1">5 (27.8%)</td><td align="center" rowspan="1" colspan="1">0.447</td></tr><tr><td rowspan="1" colspan="1">Supraventricular ectopic beats</td><td align="center" rowspan="1" colspan="1">58 (10-697)</td><td align="center" rowspan="1" colspan="1">133 (16-401)</td><td align="center" rowspan="1" colspan="1">0.903</td></tr><tr><td rowspan="1" colspan="1">Supraventricular tachycardia</td><td align="center" rowspan="1" colspan="1">0 (0-1)</td><td align="center" rowspan="1" colspan="1">0(0-1)</td><td align="center" rowspan="1" colspan="1">0.679</td></tr><tr><td rowspan="1" colspan="1">Ventricular ectopic beats</td><td align="center" rowspan="1" colspan="1">851 (583-2137)</td><td align="center" rowspan="1" colspan="1">1347 (314-2624)</td><td align="center" rowspan="1" colspan="1">0.738</td></tr><tr><td rowspan="1" colspan="1">Ventricular tachycardia</td><td align="center" rowspan="1" colspan="1">0 (0-1)</td><td align="center" rowspan="1" colspan="1">2(0-8)</td><td align="center" rowspan="1" colspan="1">0.252</td></tr></tbody></table><table-wrap-foot><fn><p>AVB: atrioventricular block; RBBB: right bundle branch block; LBBB: left
bundle-branch block; SD: standard deviation; HR: heart rate; LAHB: left anterior
hemiblock; IQ: interquartile range 1&#x02013;3 (25-75%).</p></fn><fn id="tfn01t02"><label>*</label><p>significant p value.</p></fn></table-wrap-foot></table-wrap><p>At the functional assessments at the end of the study, there was a significant improvement
in Goldman functional classification in IG patients. At the stress test, although baseline
and post-training VO<sub>2</sub> max was similar between the groups, its variation was
significantly higher in IG, as well as a significantly greater increase in test time in the
IG compared to the CG (<xref ref-type="table" rid="t03">Table 3</xref>). At 6-minute walk
test, the distance walked at baseline was similar between the groups, but at the end of the
study this distance was significantly higher in IG; the variation was also higher when
compared to the baseline (<xref ref-type="table" rid="t03">Table 3</xref>).</p><table-wrap id="t03" orientation="portrait" position="float"><label>Table 3</label><caption><p>Comparison of changes in clinical functional variables, of exercise stress test and the
six-minute walk test between the control group and the intervention group</p></caption><table frame="hsides" rules="rows"><thead><tr><th align="left" rowspan="1" colspan="1">
<bold>Variable</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Control group (n = 19)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Intervention Group (n = 18)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>p</bold>
</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Improvement in NYHA functional class (n, %)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">2 (11.1%)</td><td align="center" rowspan="1" colspan="1">0.23</td></tr><tr><td rowspan="1" colspan="1">Improvement in Goldman functional class (n, %)</td><td align="center" rowspan="1" colspan="1">1 (5.3%)</td><td align="center" rowspan="1" colspan="1">8 (44.4%)</td><td align="center" rowspan="1" colspan="1">0.008<xref ref-type="table-fn" rid="tfn01t03">*</xref></td></tr><tr><td rowspan="1" colspan="1">ST: VO<sub>2</sub> maximal pre/post-training (ml/kg/min, mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">31.4 &#x000b1; 7.2/33.5 &#x000b1; 6.8</td><td align="center" rowspan="1" colspan="1">27.3 &#x000b1; 5.7/34.3 &#x000b1; 4.9</td><td align="center" rowspan="1" colspan="1">0.07/0.71</td></tr><tr><td rowspan="1" colspan="1">ST: &#x02206;VO<sub>2</sub> maximal (ml/kg/min, mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">2.2 &#x000b1; 4.8</td><td align="center" rowspan="1" colspan="1">7.0 &#x000b1; 3.6</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001<xref ref-type="table-fn" rid="tfn01t03">*</xref></td></tr><tr><td rowspan="1" colspan="1">ST: time of test pre/post-training (min, mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">9.4 &#x000b1; 3.0/10.2 &#x000b1; 3.0</td><td align="center" rowspan="1" colspan="1">7.6 &#x000b1; 2.4/10.6 &#x000b1; 2.2</td><td align="center" rowspan="1" colspan="1">0.05/0.68</td></tr><tr><td rowspan="1" colspan="1">ST: &#x02206; time of test (min, mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">0.8 &#x000b1; 2.0</td><td align="center" rowspan="1" colspan="1">3.0 &#x000b1; 1.6</td><td align="center" rowspan="1" colspan="1">&#x0003c; 0.001<xref ref-type="table-fn" rid="tfn01t03">*</xref></td></tr><tr><td rowspan="1" colspan="1">6MWT: distance walked pre/post-training (m, mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">521.8 &#x000b1; 91.1/530.3 &#x000b1; 69.1</td><td align="center" rowspan="1" colspan="1">525.4 &#x000b1; 85.5/593.3 &#x000b1; 78.5</td><td align="center" rowspan="1" colspan="1">0.902/0.014<xref ref-type="table-fn" rid="tfn01t03">*</xref></td></tr><tr><td rowspan="1" colspan="1">6MWT: &#x02206; of walked distance (m, mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">8.4 &#x000b1; 49.1</td><td align="center" rowspan="1" colspan="1">67.8 &#x000b1; 54.7</td><td align="center" rowspan="1" colspan="1">0.001<xref ref-type="table-fn" rid="tfn01t03">*</xref></td></tr></tbody></table><table-wrap-foot><fn><p>SD: standard-deviation; NYHA: New York Heart Association; ST: stress test;
VO<sub>2</sub>: maximal oxygen uptake; 6MWT &#x02013; six-minute walk test.</p></fn><fn id="tfn01t03"><label>*</label><p>Statistically significant p value.</p></fn></table-wrap-foot></table-wrap><p>When evaluating the HRV indices in the time domain (SDNN and rMSSD), no statistically
significant variations were observed in the values at the end of the study when compared to
the baseline in both groups, and &#x02206;SDNN and &#x02206;rMSSD were similar between them
(<xref ref-type="table" rid="t04">Table 4</xref>). Regarding HRV indices in the frequency
domain (TP, VLFP, LFP and HFP), there was significant increase in TP and VLFP compared to
baseline in IG, but not in CG. The &#x02206;TP and &#x02206;VLFP values, however, were similar
between groups. Regarding HFP, there was an increase in IG and decrease in the CG (no
significant difference compared to baseline) and there was a non-statistically significant
trend of &#x02206;HFP difference between groups: 79 (61-328) vs. -42 (-133 - 92) Hz, p =
0.083.</p><table-wrap id="t04" orientation="portrait" position="float"><label>Table 4</label><caption><p>Indices of heart rate variability at baseline and at the end of the study</p></caption><table frame="hsides" rules="rows"><thead><tr><th align="left" rowspan="1" colspan="1">
<bold>Variable</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Group</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Pre</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Post</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Delta (&#x02206;)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>p (pre vs. post)</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>p (dif.)</bold>
</th></tr></thead><tbody><tr><td rowspan="2" colspan="1">SDNN (ms. mean &#x000b1; SD)</td><td align="center" rowspan="1" colspan="1">GC (n = 19)</td><td align="center" rowspan="1" colspan="1">126.4 &#x000b1; 31.3</td><td align="center" rowspan="1" colspan="1">137.9 &#x000b1; 43.0</td><td align="center" rowspan="1" colspan="1">11.5 &#x000b1; 30.0</td><td align="center" rowspan="1" colspan="1">0.112</td><td rowspan="2" align="center" colspan="1">0.102</td></tr><tr><td align="center" rowspan="1" colspan="1">GI (n = 18)</td><td align="center" rowspan="1" colspan="1">163.9 &#x000b1; 54.7</td><td align="center" rowspan="1" colspan="1">160.2 &#x000b1; 50.0</td><td align="center" rowspan="1" colspan="1">-3.7 &#x000b1; 25.1</td><td align="center" rowspan="1" colspan="1">0.536</td></tr><tr><td rowspan="2" colspan="1">rMSSD (ms. median IQ)</td><td align="center" rowspan="1" colspan="1">GC (n = 19)</td><td align="center" rowspan="1" colspan="1">27 (23-44)</td><td align="center" rowspan="1" colspan="1">39 (19-53)</td><td align="center" rowspan="1" colspan="1">2 (-6-17)</td><td align="center" rowspan="1" colspan="1">0.542</td><td rowspan="2" align="center" colspan="1"> 0.429</td></tr><tr><td align="center" rowspan="1" colspan="1">GI (n = 18)</td><td align="center" rowspan="1" colspan="1">44(30-83)</td><td align="center" rowspan="1" colspan="1">41 (32-74)</td><td align="center" rowspan="1" colspan="1">-1 (-21-9)</td><td align="center" rowspan="1" colspan="1">0.678</td></tr><tr><td rowspan="2" colspan="1">TP (Hz. median IQ)</td><td align="center" rowspan="1" colspan="1">GC (n = 19)</td><td align="center" rowspan="1" colspan="1">1526 (709-2850)</td><td align="center" rowspan="1" colspan="1">2423 (1132-4234)</td><td align="center" rowspan="1" colspan="1">943 (-731-3130)</td><td align="center" rowspan="1" colspan="1">0.091</td><td rowspan="2" align="center" colspan="1"> 0.521</td></tr><tr><td align="center" rowspan="1" colspan="1">GI (n = 18)</td><td align="center" rowspan="1" colspan="1">1653 (625-3418)</td><td align="center" rowspan="1" colspan="1">2794 (1617-4452)</td><td align="center" rowspan="1" colspan="1">1780 (921-2743)</td><td align="center" rowspan="1" colspan="1">0.017<xref ref-type="table-fn" rid="tfn01t04">*</xref></td></tr><tr><td rowspan="2" colspan="1">VLFP (Hz. median IQ)</td><td align="center" rowspan="1" colspan="1">GC (n = 19)</td><td align="center" rowspan="1" colspan="1">666 (427-1230)</td><td align="center" rowspan="1" colspan="1">1215 (527-3003)</td><td align="center" rowspan="1" colspan="1">682 (-208-2019)</td><td align="center" rowspan="1" colspan="1">0.126</td><td rowspan="2" align="center" colspan="1"> 0.849</td></tr><tr><td align="center" rowspan="1" colspan="1">GI (n = 18)</td><td align="center" rowspan="1" colspan="1">586 (290-1565)</td><td align="center" rowspan="1" colspan="1">815 (610-1425)</td><td align="center" rowspan="1" colspan="1">371 (27-1171)</td><td align="center" rowspan="1" colspan="1">0.047<xref ref-type="table-fn" rid="tfn01t04">*</xref></td></tr><tr><td rowspan="2" colspan="1">LFP (Hz. median IQ)</td><td align="center" rowspan="1" colspan="1">GC (n = 19)</td><td align="center" rowspan="1" colspan="1">124 (77-447)</td><td align="center" rowspan="1" colspan="1">202 (50-482)</td><td align="center" rowspan="1" colspan="1">-1.0 (-150-197)</td><td align="center" rowspan="1" colspan="1">0.629</td><td rowspan="2" align="center" colspan="1"> 0.849</td></tr><tr><td align="center" rowspan="1" colspan="1">GI (n = 18)</td><td align="center" rowspan="1" colspan="1">192 (38-418)</td><td align="center" rowspan="1" colspan="1">161 (76-292)</td><td align="center" rowspan="1" colspan="1">60 (-111-146)</td><td align="center" rowspan="1" colspan="1">0.733</td></tr><tr><td rowspan="2" colspan="1">HFP (Hz. median IQ)</td><td align="center" rowspan="1" colspan="1">GC (n = 19)</td><td align="center" rowspan="1" colspan="1">166 (86-291)</td><td align="center" rowspan="1" colspan="1">154 (62-422)</td><td align="center" rowspan="1" colspan="1">-42 (-133-92)</td><td align="center" rowspan="1" colspan="1">0.494</td><td rowspan="2" align="center" colspan="1"> 0.083</td></tr><tr><td align="center" rowspan="1" colspan="1">GI (n = 18)</td><td align="center" rowspan="1" colspan="1">190 (87-443)</td><td align="center" rowspan="1" colspan="1">256 (207-462)</td><td align="center" rowspan="1" colspan="1">79 (-61-328)</td><td align="center" rowspan="1" colspan="1">0.156</td></tr></tbody></table><table-wrap-foot><fn><p>SD: standard-deviation; CG: control group; IG: intervention group; HFP:
high-frequency power; IQ: interquartile range (25-75); LFP: low-frequency power;
pre-post: comparison of the results of the group at the beginning and end of the
study; rMSSD: root mean square of successive differences; SDNN: standard deviation of
NN intervals; TP: total power; VLFP: very low-frequency power.</p></fn><fn id="tfn01t04"><label>*</label><p>Statistically significant p value.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion"><title>Discussion</title><p>In this prospective, randomized therapeutic study in patients with Chagas cardiomyopathy
and left ventricular dysfunction, exercise training resulted in no significant changes in
HRV indices, although it resulted in improved functional class, as well as stress 6-minute
walk test variables. We observed an increase in only two indices of HRV in the frequency
domain (TP and VLFP) compared to the baseline in the IG, but with statistically similar
variation between groups. Additionally, there was a trend towards greater positive variation
of HFP in IG compared to CG.</p><p>HRV is reduced in Chagas patients with and without the cardiac form (including the
indeterminate form)<sup><xref rid="r06" ref-type="bibr">6</xref>,<xref rid="r07" ref-type="bibr">7</xref>,<xref rid="r09" ref-type="bibr">9</xref>,<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r23" ref-type="bibr">23</xref></sup>, and the reduction
in its indices is correlated with levels of antimuscarinic antibodies<sup><xref rid="r10" ref-type="bibr">10</xref></sup>, which are increased in infected patients. The
levels of these antibodies seem to be associated with clinical markers of autonomic
dysfunction<sup><xref rid="r24" ref-type="bibr">24</xref></sup>, including the reduction
of the chronotropic response to stress, suggesting clinical and physiopathological
significance in Chagas disease<sup><xref rid="r25" ref-type="bibr">25</xref></sup>. It is
controversial the existence of an association between reduced HRV autonomic dysfunction
marker and severity of ventricular dysfunction or the evolutionary stage of the
disease<sup><xref rid="r26" ref-type="bibr">26</xref>-<xref rid="r31" ref-type="bibr">31</xref></sup>.</p><p>Although the prognostic value of HRV reduction has not been demonstrated in Chagas'
disease, it is known that in several cardiac and systemic diseases, reduced HRV is a strong
and independent prognostic marker, with good prediction of adverse events<sup><xref rid="r12" ref-type="bibr">12</xref>-<xref rid="r14" ref-type="bibr">14</xref></sup>. In
heart failure from other causes, there is an association between reduced indices with
adverse events, such as decompensation, hospital readmissions, ventricular dysfunction
progression and mortality<sup><xref rid="r32" ref-type="bibr">32</xref>-<xref rid="r34" ref-type="bibr">34</xref></sup>.</p><p>Some methodological issues should be considered in the analysis of our data, especially
regarding the variability of HRV indices between different measures. The reproducibility of
these variables at rest and during stress has been previously demonstrated<sup><xref rid="r35" ref-type="bibr">35</xref></sup>, but other studies suggest that although the
indices in the time domain (SDNN and rMSSD) are reproducible, the same is not true in
relation to the frequency domain variables obtained by spectral analysis<sup><xref rid="r36" ref-type="bibr">36</xref>,<xref rid="r37" ref-type="bibr">37</xref></sup>.
Thus, considering the sample size calculation based on the time domain index, the
interpretation of negative results in the frequency domain should be made with caution.
Furthermore, our data dispersion was generally higher than that observed in those
studies.</p><p>Regular physical activity is known to be beneficial in heart failure<sup><xref rid="r38" ref-type="bibr">38</xref></sup>, with improved functional capacity and
possible prognostic impact. Pooled data suggest an effect on serum prognostic markers such
as B-type natriuretic peptide and functional variables in specific subgroups<sup><xref rid="r39" ref-type="bibr">39</xref></sup>. Moreover, supervised activity programs have a
beneficial effect on HRV indices in healthy subjects and in patients with ventricular
dysfunction of different etiologies at different stages and clinical contexts<sup><xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r40" ref-type="bibr">40</xref>,<xref rid="r41" ref-type="bibr">41</xref></sup>,
data that somehow have biological plausibility, considering the abnormal behavior of the
sympathetic and parasympathetic modulation in the disease. In a way, it would be possible to
propose the assessment of HRV as an objective marker of the beneficial effects of physical
training.</p><p>Similarly to ventricular dysfunction from other etiologies, physical training seems to have
a beneficial effect in patients with Chagas cardiomyopathy, both in functional capacity and
mortality<sup><xref rid="r08" ref-type="bibr">8</xref>,<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r42" ref-type="bibr">42</xref></sup>. However, the beneficial
effect of exercise training on cardiac autonomic control, observed in other diseases, has
not been demonstrated in Chagas heart disease.</p><p>Sousa et al<sup><xref rid="r18" ref-type="bibr">18</xref></sup> verified that the strong
association observed in normal individuals between the intensity of physical activity and
vagal HRV indices was not present in chagasic patients, suggesting that in Chagas disease,
the usual vagotonic effect of exercise is not observed. More recently, Souza et al<sup><xref rid="r18" ref-type="bibr">18</xref></sup> evaluated indices of the time domain before
and after a supervised exercise program in 18 chagasic patients and found no differences in
the indices after training<sup><xref rid="r05" ref-type="bibr">5</xref></sup>. This lack of
response expected from the increased vagal tone with aerobic training could be explained by
the characteristics of the autonomic dysfunction in early Chagas disease, relatively
independent from left ventricular dysfunction and associated to antimuscarinic
autoantibodies<sup><xref rid="r01" ref-type="bibr">1</xref></sup>. Another possibility
is that the impairment of the cardiac excitoconductive system, particularly the sinus
node<sup><xref rid="r01" ref-type="bibr">1</xref></sup>, impair the capacity of the
parasympathetic ANS to modulate the beat-to-beat variation, typical of HRV.</p><p>At any rate, one might suspect that the clinical benefits observed with aerobic training in
patients with Chagas cardiomyopathy do not involve the potential benefits of increased vagal
tone, such as a decrease in the risk of sudden death<sup><xref rid="r18" ref-type="bibr">18</xref></sup>. Despite methodological considerations in the evaluation of HRV, this
hypothesis has been consistently tested in our study, with an exercise program of which
effectiveness was assessed clinically and functionally, and which application did not result
in any significant changes in HRV indices.</p><sec><title>Limitations</title><p>The analysis of HRV indices showed greater variability than initially expected, which may
be related to physiopathological characteristics of Chagas heart disease. For this reason,
sampling limitations may have hindered the detection of statistical differences between
the groups (type I error). The trend to the difference observed between the groups
regarding &#x02206;HFP could be confirmed or not with a larger sample. Furthermore, in
spite of the sample randomization and considerable similarity between the groups, small
differences in baseline (such as mean and minimum HR at Holter) can influence the
interpretation of results.</p><p>The time of exercise training may also have been insufficient for the detection of
changes, considering the sample size, as well as its intensity (mild to moderate).
However, longer training periods also did not result in significant changes in HRV
indices, as shown in a previous study<sup><xref rid="r05" ref-type="bibr">5</xref></sup>.
Moreover, the absence of isometric exercises, as recommended by guidelines for cardiac
rehabilitation, may also have contributed to the negative result. Finally, the effect of
training in the IG could have been more objectively evaluated through functional testing
with analysis of expired gases.</p></sec></sec><sec sec-type="conclusions"><title>Conclusions</title><p>In the studied population, exercise training did not significantly alter HRV indices in
Chagas patients with LV dysfunction, although it resulted in functional improvement. The
only changes observed in relation to baseline were increased TP and VLFP in the IG, with no
significant difference in changes between groups. The data are consistent with previous
publications and suggest that the clinical benefits of physical conditioning in Chagas heart
disease are independent from HRV indices. Future studies in larger populations are needed in
order to reach more definitive conclusions about the behavior of HRV during physical
conditioning in Chagas heart disease.</p></sec></body><back><fn-group><fn fn-type="con"><p>
<bold>Author contributions</bold>
</p><p>Conception and design of the research: Nascimento BR, Lima MMO, Rocha MOC, Ribeiro AL;
Acquisition of data: Lima, MMO, Nunes MCP, Alencar MCN, Costa HS, Pinto Filho MM, Cota
VES; Analysis and interpretation of the data: Nascimento BR, Lima MMO, Pinto Filho MM,
Cota VES; Obtaining financing: Rocha MOC, Ribeiro AL; Writing of the manuscript:
Nascimento BR, Lima MMO; Critical revision of the manuscript for intellectual content:
Rocha MOC, Ribeiro AL.</p></fn><fn fn-type="conflict"><p>
<bold>Potential Conflict of Interest</bold>
</p><p>No potential conflict of interest relevant to this article was reported.</p></fn><fn fn-type="other"><p>
<bold>Study Association</bold>
</p><p>This article is part of the thesis of Doctoral submitted by M&#x000e1;rcia Maria Oliveira
Lima, from Universidade Federal de Minas Gerais.</p></fn><fn fn-type="financial-disclosure"><p>
<bold>Sources of Funding</bold>
</p><p>This study was funded by CNPq, FAPEMIG and CAPES.</p></fn></fn-group><ref-list><title>References</title><ref id="r01"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes</surname><given-names>MC</given-names></name><name><surname>Dones</surname><given-names>W</given-names></name><name><surname>Morillo</surname><given-names>CA</given-names></name><name><surname>Encina</surname><given-names>JJ</given-names></name><name><surname>Ribeiro</surname><given-names>AL</given-names></name><collab>Council on Chagas Disease of the Interamerican Society of Cardiology</collab></person-group><article-title>Chagas disease: an overview of clinical and epidemiological
aspects</article-title><source>J Am Coll Cardiol</source><year>2013</year><volume>62</volume><issue>9</issue><fpage>767</fpage><lpage>776</lpage><pub-id pub-id-type="pmid">23770163</pub-id></element-citation></ref><ref id="r02"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biolo</surname><given-names>A</given-names></name><name><surname>Ribeiro</surname><given-names>AL</given-names></name><name><surname>Clausell</surname><given-names>N</given-names></name></person-group><article-title>Chagas cardiomyopathy: where do we stand after a hundred
years?</article-title><source>Prog Cardiovasc Dis</source><year>2010</year><volume>52</volume><issue>4</issue><fpage>300</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">20109600</pub-id></element-citation></ref><ref id="r03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>AL</given-names></name><name><surname>Nunes</surname><given-names>MP</given-names></name><name><surname>Teixeira</surname><given-names>MM</given-names></name><name><surname>Rocha</surname><given-names>MO</given-names></name></person-group><article-title>Diagnosis and management of Chagas disease and
cardiomyopathy</article-title><source>Nat Rev Cardiol</source><year>2012</year><volume>9</volume><issue>10</issue><fpage>576</fpage><lpage>589</lpage><pub-id pub-id-type="pmid">22847166</pub-id></element-citation></ref><ref id="r04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>MO</given-names></name><name><surname>Teixeira</surname><given-names>MM</given-names></name><name><surname>Ribeiro</surname><given-names>AL</given-names></name></person-group><article-title>Anupdateonthe management of Chagas cardiomyopathy</article-title><source>Expert Rev Anti Infect Ther</source><year>2007</year><volume>5</volume><issue>4</issue><fpage>727</fpage><lpage>743</lpage><pub-id pub-id-type="pmid">17678433</pub-id></element-citation></ref><ref id="r05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amaral da Silva Souza</surname><given-names>MV</given-names></name><name><surname>Santos Soares</surname><given-names>CC</given-names></name><name><surname>Rega de Oliveira</surname><given-names>J</given-names></name><name><surname>Rosa de Oliveira</surname><given-names>C</given-names></name><name><surname>Hargreaves Fialho</surname><given-names>P</given-names></name><name><surname>Cunha</surname><given-names>DM</given-names></name><etal>et al</etal></person-group><article-title>Heart rate variability: analysis of time-domain indices in patients with
chronic Chagas disease before and after an exercise program</article-title><source>Rev Port Cardiol</source><year>2013</year><volume>32</volume><issue>3</issue><fpage>219</fpage><lpage>227</lpage><pub-id pub-id-type="pmid">23499156</pub-id></element-citation></ref><ref id="r06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Resende</surname><given-names>LA</given-names></name><name><surname>Carneiro</surname><given-names>AC</given-names></name><name><surname>Ferreira</surname><given-names>BD</given-names></name><name><surname>Silva</surname><given-names>RA</given-names></name><name><surname>Silva</surname><given-names>VJ</given-names></name><name><surname>Prata</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title xml:lang="pt">An&#x000e1;lise temporal da variabilidade da frequ&#x000ea;ncia
card&#x000ed;aca no estado basal em idosos chag&#x000e1;sicos na forma indeterminada em
&#x000e1;rea end&#x000ea;mica</article-title><source>Rev Soc Bras Med Trop</source><year>2003</year><volume>36</volume><issue>6</issue><fpage>703</fpage><lpage>706</lpage><pub-id pub-id-type="pmid">15049110</pub-id></element-citation></ref><ref id="r07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzzetti</surname><given-names>S</given-names></name><name><surname>Iosa</surname><given-names>D</given-names></name><name><surname>Pecis</surname><given-names>M</given-names></name><name><surname>Bonura</surname><given-names>L</given-names></name><name><surname>Prosdocimi</surname><given-names>M</given-names></name><name><surname>Malliani</surname><given-names>A</given-names></name></person-group><article-title>Impaired heart rate variability in patients with chronic Chagas'
disease</article-title><source>Am Heart J</source><year>1991</year><volume>121</volume><issue>6</issue><issue-part>Pt 1</issue-part><fpage>1727</fpage><lpage>1734</lpage><pub-id pub-id-type="pmid">1903581</pub-id></element-citation></ref><ref id="r08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritt</surname><given-names>LE</given-names></name><name><surname>Carvalho</surname><given-names>AC</given-names></name><name><surname>Feitosa</surname><given-names>GS</given-names></name><name><surname>Pinho-Filho</surname><given-names>JA</given-names></name><name><surname>Andrade</surname><given-names>MV</given-names></name><name><surname>Feitosa-Filho</surname><given-names>GS</given-names></name><etal>et al</etal></person-group><article-title>Cardiopulmonary exercise and 6-min walk tests as predictors of quality of
life and long-term mortality among patients with heart failure due to Chagas
disease</article-title><source>Int J Cardiol</source><year>2013</year><volume>168</volume><issue>4</issue><fpage>4584</fpage><lpage>4585</lpage><pub-id pub-id-type="pmid">23871619</pub-id></element-citation></ref><ref id="r09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>AL</given-names></name><name><surname>Lombardi</surname><given-names>F</given-names></name><name><surname>da Costa Rocha</surname><given-names>MO</given-names></name><name><surname>Barros</surname><given-names>MV</given-names></name><name><surname>Val Barros Vda</surname><given-names>C</given-names></name><name><surname>Reis</surname><given-names>AM</given-names></name><etal>et al</etal></person-group><article-title>Chronotropic incompetence and abnormal autonomic modulation in ambulatory
Chagas disease patients</article-title><source>Ann Noninvasive Electrocardiol</source><year>2006</year><volume>11</volume><issue>1</issue><fpage>3</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">16472276</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>AL</given-names></name><name><surname>Gimenez</surname><given-names>LE</given-names></name><name><surname>Hernandez</surname><given-names>CC</given-names></name><name><surname>Carvalho</surname><given-names>AC</given-names></name><name><surname>Teixeira</surname><given-names>MM</given-names></name><name><surname>Guedes</surname><given-names>VC</given-names></name><etal>et al</etal></person-group><article-title>Early occurrence of anti-muscarinic autoantibodies and abnormal vagal
modulation in Chagas disease</article-title><source>Int J Cardiol</source><year>2007</year><volume>117</volume><issue>1</issue><fpage>59</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">16859766</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>AL</given-names></name><name><surname>Moraes</surname><given-names>RS</given-names></name><name><surname>Ribeiro</surname><given-names>JP</given-names></name><name><surname>Ferlin</surname><given-names>EL</given-names></name><name><surname>Torres</surname><given-names>RM</given-names></name><name><surname>Oliveira</surname><given-names>E</given-names></name><etal>et al</etal></person-group><article-title>Parasympathetic dysautonomia precedes left ventricular systolic dysfunction
in Chagas disease</article-title><source>Am Heart J</source><year>2001</year><volume>141</volume><issue>2</issue><fpage>260</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">11174350</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>A</given-names></name><name><surname>Barthel</surname><given-names>P</given-names></name><name><surname>Schneider</surname><given-names>R</given-names></name><name><surname>Ulm</surname><given-names>K</given-names></name><name><surname>Muller</surname><given-names>A</given-names></name><name><surname>Joeinig</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Improved stratification of autonomic regulation for risk prediction in
post-infarction patients with preserved left ventricular function
(ISAR-risk)</article-title><source>Eur Heart J</source><year>2009</year><volume>30</volume><issue>5</issue><fpage>576</fpage><lpage>583</lpage><pub-id pub-id-type="pmid">19109245</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>La Rovere</surname><given-names>MT</given-names></name><name><surname>Pinna</surname><given-names>GD</given-names></name><name><surname>Maestri</surname><given-names>R</given-names></name><name><surname>Barlera</surname><given-names>S</given-names></name><name><surname>Bernardinangeli</surname><given-names>M</given-names></name><name><surname>Veniani</surname><given-names>M</given-names></name><etal>et al</etal><collab>GISSI-HF Investigators</collab></person-group><article-title>Autonomic markers and cardiovascular and arrhythmic events in heart failure
patients: still a place in prognostication? Datafromthe GISSI-HF trial</article-title><source>Eur J Heart Fail</source><year>2012</year><volume>14</volume><issue>12</issue><fpage>1410</fpage><lpage>1419</lpage><pub-id pub-id-type="pmid">22851700</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Nascimento</surname><given-names>BR</given-names></name><name><surname>Coelho</surname><given-names>TO</given-names></name><name><surname>Ribeiro</surname><given-names>AL</given-names></name></person-group><article-title>Variabilidade da frequ&#x000ea;ncia card&#x000ed;aca em pacientes
criticamente enfermos</article-title><person-group person-group-type="author"><name><surname>Botoni</surname><given-names>FA</given-names></name><name><surname>Dias</surname><given-names>FS</given-names></name></person-group><source xml:lang="pt">PROAMI. Programa de atualiza&#x000e7;&#x000e3;o em medicina
intensiva</source><publisher-loc>Porto Alegre</publisher-loc><publisher-name>Artmed Panamericana</publisher-name><year>2009</year></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsen</surname><given-names>AI</given-names></name><name><surname>Gjesdal</surname><given-names>K</given-names></name><name><surname>Hall</surname><given-names>C</given-names></name><name><surname>Aukrust</surname><given-names>P</given-names></name><name><surname>Aarsland</surname><given-names>T</given-names></name><name><surname>Dickstein</surname><given-names>K</given-names></name></person-group><article-title>Effect of exercise training in patients with heart failure: a pilot study
on autonomic balance assessed by heart rate variability</article-title><source>Eur J Cardiovasc Prev Rehabil</source><year>2004</year><volume>11</volume><issue>2</issue><fpage>162</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">15187821</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iellamo</surname><given-names>F</given-names></name><name><surname>Manzi</surname><given-names>V</given-names></name><name><surname>Caminiti</surname><given-names>G</given-names></name><name><surname>Sposato</surname><given-names>B</given-names></name><name><surname>Massaro</surname><given-names>M</given-names></name><name><surname>Cerrito</surname><given-names>A</given-names></name><etal>et al</etal></person-group><article-title>Dose-response relationship of baroreflex sensitivity and heart rate
variability to individually-tailored exercise training in patients with heart
failure</article-title><source>Int J Cardiol</source><year>2013</year><volume>166</volume><issue>2</issue><fpage>334</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">22078985</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconcelos</surname><given-names>DF</given-names></name><name><surname>Junqueira</surname><given-names>LF</given-names><suffix>Jr</suffix></name></person-group><article-title>Distinctive impaired cardiac autonomic modulation of heart rate variability
in chronic Chagas' indeterminate and heart diseases</article-title><source>J Electrocardiol</source><year>2009</year><volume>42</volume><issue>3</issue><fpage>281</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">19095247</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sousa</surname><given-names>L</given-names></name><name><surname>Rocha</surname><given-names>MO</given-names></name><name><surname>Britto</surname><given-names>RR</given-names></name><name><surname>Lombardi</surname><given-names>F</given-names></name><name><surname>Ribeiro</surname><given-names>AL</given-names></name></person-group><article-title>Chagas disease alters the relationship between heart rate variability and
daily physical activity</article-title><source>Int J Cardiol</source><year>2009</year><volume>135</volume><issue>2</issue><fpage>257</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">18585804</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lima</surname><given-names>MM</given-names></name><name><surname>Rocha</surname><given-names>MO</given-names></name><name><surname>Nunes</surname><given-names>MC</given-names></name><name><surname>Sousa</surname><given-names>L</given-names></name><name><surname>Costa</surname><given-names>HS</given-names></name><name><surname>Alencar</surname><given-names>MC</given-names></name><etal>et al</etal></person-group><article-title>A randomized trial of the effects of exercise training in Chagas
cardiomyopathy</article-title><source>Eur J Heart Fail</source><year>2010</year><volume>12</volume><issue>8</issue><fpage>866</fpage><lpage>873</lpage><pub-id pub-id-type="pmid">20675669</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickstein</surname><given-names>K</given-names></name><name><surname>Cohen-Solal</surname><given-names>A</given-names></name><name><surname>Filippatos</surname><given-names>G</given-names></name><name><surname>McMurray</surname><given-names>JJ</given-names></name><name><surname>Ponikowski</surname><given-names>P</given-names></name><name><surname>Poole-Wilson</surname><given-names>PA</given-names></name><etal>et al</etal></person-group><article-title>ESC guidelines for the diagnosis and treatment of acute and chronic heart
failure 2008: The task force for the diagnosis and treatment of acute and chronic heart
failure 2008 of the European Society of Cardiology. Developed in collaboration with the
heart failure association of the ESC (HFA) and endorsed by the European Society of
Intensive Care Medicine (ESICM)</article-title><source>Eur Heart J</source><year>2008</year><volume>29</volume><issue>19</issue><fpage>2388</fpage><lpage>2442</lpage><comment>Erratum in: Eur Heart J. 2010;12(4):416, Eur Heart J. 2010;31(5):624.</comment><pub-id pub-id-type="pmid">18799522</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>ATS Committee on Proficiency Standards for Clinical Pulmonary Function
Laboratories</collab></person-group><article-title>ATS Statement: guidelines for the six-minute test</article-title><source>Am J Respir Crit Care Med</source><year>2002</year><volume>166</volume><issue>1</issue><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">12091180</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>J</given-names></name></person-group><article-title>Principles of exercise prescription for patients with chronic heart
failure</article-title><source>Heart Fail Rev</source><year>2008</year><volume>13</volume><issue>1</issue><fpage>61</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">17939037</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>AL</given-names></name><name><surname>Cassini</surname><given-names>P</given-names></name><name><surname>Peixoto</surname><given-names>SV</given-names></name><name><surname>Lima-Costa</surname><given-names>MF</given-names></name></person-group><article-title>Vagal impairment in elderly Chagas disease patients: a population-based
study (the Bambui study)</article-title><source>Int J Cardiol</source><year>2011</year><volume>147</volume><issue>3</issue><fpage>359</fpage><lpage>365</lpage><pub-id pub-id-type="pmid">19875184</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiers</surname><given-names>CA</given-names></name><name><surname>Barbosa</surname><given-names>JL</given-names></name><name><surname>Pereira Bde</surname><given-names>B</given-names></name><name><surname>Nascimento</surname><given-names>EM</given-names></name><name><surname>Nascimento</surname><given-names>JH</given-names></name><name><surname>Medei</surname><given-names>EH</given-names></name><etal>et al</etal></person-group><article-title>Autonomic dysfunction and anti-M2 and anti-beta 1 receptor antibodies in
Chagas disease patients</article-title><source>Arq Bras Cardiol</source><year>2012</year><volume>99</volume><issue>2</issue><fpage>732</fpage><lpage>739</lpage><pub-id pub-id-type="pmid">22790404</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talvani</surname><given-names>A</given-names></name><name><surname>Rocha</surname><given-names>MO</given-names></name><name><surname>Ribeiro</surname><given-names>AL</given-names></name><name><surname>Borda</surname><given-names>E</given-names></name><name><surname>Sterin-Borda</surname><given-names>L</given-names></name><name><surname>Teixeira</surname><given-names>MM</given-names></name></person-group><article-title>Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the
degree of heart dysfunction in Chagas' heart disease</article-title><source>Microbes Infect</source><year>2006</year><volume>8</volume><issue>9-10</issue><fpage>2459</fpage><lpage>2464</lpage><pub-id pub-id-type="pmid">16963301</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>AL</given-names></name><name><surname>Lombardi</surname><given-names>F</given-names></name><name><surname>Sousa</surname><given-names>MR</given-names></name><name><surname>Lins Barros</surname><given-names>MV</given-names></name><name><surname>Porta</surname><given-names>A</given-names></name><name><surname>Costa Val Barros</surname><given-names>V</given-names></name><etal>et al</etal></person-group><article-title>Power-law behavior of heart rate variability in Chagas'
disease</article-title><source>Am J Cardiol</source><year>2002</year><volume>89</volume><issue>4</issue><fpage>414</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">11835922</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villar</surname><given-names>JC</given-names></name><name><surname>Leon</surname><given-names>H</given-names></name><name><surname>Morillo</surname><given-names>CA</given-names></name></person-group><article-title>Cardiovascular autonomic function testing in asymptomatic T. cruzi
carriers: a sensitive method to identify subclinical Chagas' disease</article-title><source>Int J Cardiol</source><year>2004</year><volume>93</volume><issue>2-3</issue><fpage>189</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">14975546</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tundo</surname><given-names>F</given-names></name><name><surname>Lombardi</surname><given-names>F</given-names></name><name><surname>Rocha</surname><given-names>MC</given-names></name><name><surname>Botoni</surname><given-names>F</given-names></name><name><surname>Schmidt</surname><given-names>G</given-names></name><name><surname>Barros</surname><given-names>VC</given-names></name><etal>et al</etal></person-group><article-title>Heart rate turbulence and left ventricular ejection fraction in Chagas
disease</article-title><source>Europace</source><year>2005</year><volume>7</volume><issue>3</issue><fpage>197</fpage><lpage>203</lpage><pub-id pub-id-type="pmid">15878555</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconcelos</surname><given-names>DF</given-names></name><name><surname>Junqueira</surname><given-names>LF</given-names><suffix>Jr</suffix></name></person-group><article-title xml:lang="pt">Fun&#x000e7;&#x000f5;es auton&#x000f4;mica e mec&#x000e2;nica
ventricular na cardiopatia chag&#x000e1;sica cr&#x000f4;nica
assintom&#x000e1;tica</article-title><source>Arq Bras Cardiol</source><year>2012</year><volume>98</volume><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">22218415</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davila</surname><given-names>DF</given-names></name><name><surname>Inglessis</surname><given-names>G</given-names></name><name><surname>Mazzei de Davila</surname><given-names>CA</given-names></name></person-group><article-title>Chagas' heart disease and the autonomic nervous system</article-title><source>Int J Cardiol</source><year>1998</year><volume>66</volume><issue>2</issue><fpage>123</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">9829322</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina</surname><given-names>RB</given-names></name><name><surname>Matsubara</surname><given-names>BB</given-names></name><name><surname>Hueb</surname><given-names>JC</given-names></name><name><surname>Zanati</surname><given-names>SG</given-names></name><name><surname>Meira</surname><given-names>DA</given-names></name><name><surname>Cassolato</surname><given-names>JL</given-names></name><etal>et al</etal></person-group><article-title>Dysautonomia and ventricular dysfunction in the indeterminate form of
Chagas disease</article-title><source>Int J Cardiol</source><year>2006</year><volume>113</volume><issue>2</issue><fpage>188</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">16376440</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanindi</surname><given-names>A</given-names></name><name><surname>Olgun</surname><given-names>H</given-names></name><name><surname>Celik</surname><given-names>B</given-names></name><name><surname>Boyaci</surname><given-names>B</given-names></name></person-group><article-title>Heart rate variability in patients hospitalized for decompensated diastolic
heart failure at admission and after clinical stabilization</article-title><source>Future Cardiol</source><year>2012</year><volume>8</volume><issue>3</issue><fpage>473</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">22642636</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arsenos</surname><given-names>P</given-names></name><name><surname>Gatzoulis</surname><given-names>K</given-names></name><name><surname>Manis</surname><given-names>G</given-names></name><name><surname>Gialernios</surname><given-names>T</given-names></name><name><surname>Dilaveris</surname><given-names>P</given-names></name><name><surname>Tsiachris</surname><given-names>D</given-names></name><etal>et al</etal></person-group><article-title>Decreased scale-specific heart rate variability after multi resolution
wavelet analysis predicts sudden cardiac death in heart failure patients</article-title><source>Int J Cardiol</source><year>2012</year><volume>154</volume><issue>3</issue><fpage>358</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">22133464</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>YL</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>YH</given-names></name><name><surname>Lo</surname><given-names>MT</given-names></name></person-group><article-title>The prognostic value of non-linear analysis of heart rate variability in
patients with congestive heart failure: a pilot study of multiscale
entropy</article-title><source>PloS One</source><year>2011</year><volume>6</volume><issue>4</issue><elocation-id/></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNarry</surname><given-names>MA</given-names></name><name><surname>Lewis</surname><given-names>MJ</given-names></name></person-group><article-title>Heart rate variability reproducibility during exercise</article-title><source>Physiol Meas</source><year>2012</year><volume>33</volume><issue>7</issue><fpage>1123</fpage><lpage>1133</lpage><pub-id pub-id-type="pmid">22736226</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tannus</surname><given-names>LR</given-names></name><name><surname>Sperandei</surname><given-names>S</given-names></name><name><surname>Montenegro J&#x000fa;nior</surname><given-names>RM</given-names></name><name><surname>Carvalho</surname><given-names>VR</given-names></name><name><surname>Pedrosa</surname><given-names>HC</given-names></name><name><surname>F&#x000e9;lix</surname><given-names>MT</given-names></name><etal>et al</etal></person-group><article-title>Reproducibility of methods used for the assessment of autonomous nervous
system's function</article-title><source>Auton Neurosci</source><year>2013</year><volume>177</volume><issue>2</issue><fpage>275</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">23770193</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ginsburg</surname><given-names>P</given-names></name><name><surname>Bartur</surname><given-names>G</given-names></name><name><surname>Peleg</surname><given-names>S</given-names></name><name><surname>Vatine</surname><given-names>JJ</given-names></name><name><surname>Katz-Leurer</surname><given-names>M</given-names></name></person-group><article-title>Reproducibility of heart rate variability during rest, paced breathing and
light-to-moderate intense exercise in patients one month after stroke</article-title><source>Eur Neurol</source><year>2011</year><volume>66</volume><issue>2</issue><fpage>117</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">21849788</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMurray</surname><given-names>JJ</given-names></name><name><surname>Adamopoulos</surname><given-names>S</given-names></name><name><surname>Anker</surname><given-names>SD</given-names></name><name><surname>Auricchio</surname><given-names>A</given-names></name><name><surname>B&#x000f6;hm</surname><given-names>M</given-names></name><name><surname>Dickstein</surname><given-names>K</given-names></name><etal>et al</etal><collab>ESC Committee for Practice Guidelines</collab></person-group><article-title>Esc guidelines for the diagnosis and treatment of acute and chronic heart
failure 2012: The task force for the diagnosis and treatment of acute and chronic heart
failure 2012 of the European Society of Cardiology. Developed in collaboration with the
heart failure association (HFA) of the ESC</article-title><source>Eur J Heart Fail</source><year>2012</year><volume>14</volume><issue>8</issue><fpage>803</fpage><lpage>869</lpage><comment>Erratum in Eur J Heart Fail. 2013;15(3):361-2.</comment><pub-id pub-id-type="pmid">22828712</pub-id></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cipriano</surname><given-names>G Jr</given-names></name><name><surname>Cipriano</surname><given-names>VT</given-names></name><name><surname>da Silva</surname><given-names>VZ</given-names></name><name><surname>Cipriano</surname><given-names>GF</given-names></name><name><surname>Chiappa</surname><given-names>GR</given-names></name><name><surname>de Lima</surname><given-names>AC</given-names></name><etal>et al</etal></person-group><article-title>Aerobic exercise effect on prognostic markers for systolic heart failure
patients: a systematic review and meta-analysis</article-title><source>Heart Fail Rev</source><day>16</day><month>10</month><year>2013</year><comment>[Epub ahead of print]</comment></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murad</surname><given-names>K</given-names></name><name><surname>Brubaker</surname><given-names>PH</given-names></name><name><surname>Fitzgerald</surname><given-names>DM</given-names></name><name><surname>Morgan</surname><given-names>TM</given-names></name><name><surname>Goff</surname><given-names>DC</given-names><suffix>Jr</suffix></name><name><surname>Soliman</surname><given-names>EZ</given-names></name><etal>et al</etal></person-group><article-title>Exercise training improves heart rate variability in older patients with
heart failure: a randomized, controlled, single-blinded trial</article-title><source>Congest Heart Fail</source><year>2012</year><volume>18</volume><issue>4</issue><fpage>192</fpage><lpage>197</lpage><pub-id pub-id-type="pmid">22536936</pub-id></element-citation></ref><ref id="r41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Routledge</surname><given-names>FS</given-names></name><name><surname>Campbell</surname><given-names>TS</given-names></name><name><surname>McFetridge-Durdle</surname><given-names>JA</given-names></name><name><surname>Bacon</surname><given-names>SL</given-names></name></person-group><article-title>Improvements in heart rate variability with exercise
therapy</article-title><source>Can Jo Cardiol</source><year>2010</year><volume>26</volume><issue>6</issue><fpage>303</fpage><lpage>312</lpage></element-citation></ref><ref id="r42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fialho</surname><given-names>PH</given-names></name><name><surname>Tura</surname><given-names>BR</given-names></name><name><surname>Sousa</surname><given-names>AS</given-names></name><name><surname>Oliveira</surname><given-names>CR</given-names></name><name><surname>Soares</surname><given-names>CC</given-names></name><name><surname>Oliveira</surname><given-names>JR</given-names></name><etal>et al</etal></person-group><article-title xml:lang="pt">Efeitos de um programa de exerc&#x000ed;cios sobre a
capacidade funcional de pacientes com cardiopatia chag&#x000e1;sica cr&#x000f4;nica,
avaliados por teste cardiopulmonar</article-title><source>Rev Soc Bras Med Trop</source><year>2012</year><volume>45</volume><issue>2</issue><fpage>220</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">22534996</pub-id></element-citation></ref></ref-list></back></article>